Location History:
- Arlington, TX (US) (2001)
- The Woodlands, TX (US) (2002)
Company Filing History:
Years Active: 2001-2002
Title: Lori K Weimer: Innovator in Ophthalmic Formulations
Introduction
Lori K Weimer is a prominent inventor based in The Woodlands, TX (US). She has made significant contributions to the field of ophthalmology, particularly in the development of innovative treatments for dry eye disorders. With a total of 2 patents, her work has garnered attention for its potential impact on eye health.
Latest Patents
Lori's latest patents include compositions containing hydroxyeicosatetraenoic acid derivatives and methods of use in treating dry eye disorders. These compositions are designed to address the challenges associated with dry eye by utilizing HETE derivatives in combination with ethanol. Another notable patent focuses on a method of inhibiting cytokine release from human ocular cells. This ophthalmic formulation, which contains 11-(3-dimethylaminopropylidene)-6,11-dihydrodibenz[b,e]oxepin-2-acetic acid or its pharmaceutically acceptable salt, is aimed at treating or preventing ocular neovascularization and non-allergic inflammatory disorders.
Career Highlights
Throughout her career, Lori has worked with leading companies in the ophthalmic field, including Alcon Universal Ltd. and Alcon Laboratories, Inc. Her experience in these organizations has allowed her to develop and refine her innovative ideas, contributing to advancements in eye care.
Collaborations
Lori has collaborated with notable professionals in her field, including Daniel A Gamache and John M Yanni. These partnerships have further enhanced her research and development efforts, leading to impactful innovations.
Conclusion
Lori K Weimer's contributions to ophthalmic formulations demonstrate her commitment to improving eye health through innovative solutions. Her patents reflect a deep understanding of the complexities of ocular disorders and a dedication to finding effective treatments.